<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
    <record>
        <controlfield tag="001">86997</controlfield>
        <controlfield tag="005">20200716101534.0</controlfield>
        <datafield tag="024" ind1="7" ind2=" ">
            <subfield code="2">doi</subfield>
            <subfield code="a">10.3390/cancers11060808</subfield>
        </datafield>
        <datafield tag="024" ind1="8" ind2=" ">
            <subfield code="2">sideral</subfield>
            <subfield code="a">115388</subfield>
        </datafield>
        <datafield tag="037" ind1=" " ind2=" ">
            <subfield code="a">ART-2019-115388</subfield>
        </datafield>
        <datafield tag="041" ind1=" " ind2=" ">
            <subfield code="a">eng</subfield>
        </datafield>
        <datafield tag="100" ind1=" " ind2=" ">
            <subfield code="a">Dufait, Inès</subfield>
        </datafield>
        <datafield tag="245" ind1=" " ind2=" ">
            <subfield code="a">Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells</subfield>
        </datafield>
        <datafield tag="260" ind1=" " ind2=" ">
            <subfield code="c">2019</subfield>
        </datafield>
        <datafield tag="506" ind1="0" ind2=" ">
            <subfield code="a">Access copy available to the general public</subfield>
            <subfield code="f">Unrestricted</subfield>
        </datafield>
        <datafield tag="520" ind1="3" ind2=" ">
            <subfield code="a">A wide-range of myeloid-derived suppressor cell (MDSC)-mediated immune suppressive functions has previously been described. Nevertheless, potential novel mechanisms by which MDSCs aid tumor progression are, in all likelihood, still unrecognized. Next to its well-known expression in natural killer cells and cytotoxic T lymphocytes (CTLs), granzyme B (GzmB) expression has been found in different cell types. In an MDSC culture model, we demonstrated perforin and GzmB expression. Furthermore, similar observations were made in MDSCs isolated from tumor-bearing mice. Even in MDSCs from humans, GzmB expression was demonstrated. Of note, B16F10 melanoma cells co-cultured with perforin/GzmB knock out mice (KO) MDSCs displayed a remarkable decrease in invasive potential. B16F10 melanoma cells co-injected with KO MDSCs, displayed a significant slower growth curve compared to tumor cells co-injected with wild type (WT) MDSCs. In vivo absence of perforin/GzmB in MDSCs resulted in a higher number of CD8+ T-cells. Despite this change in favor of CD8+ T-cell infiltration, we observed low interferon-¿ (IFN-¿) and high programmed death-ligand 1 (PD-L1) expression, suggesting that other immunosuppressive mechanisms render these CD8+ T-cells dysfunctional. Taken together, our results suggest that GzmB expression in MDSCs is another means to promote tumor growth and warrants further investigation to unravel the exact underlying mechanism.</subfield>
        </datafield>
        <datafield tag="536" ind1=" " ind2=" ">
            <subfield code="9">info:eu-repo/grantAgreement/ES/DGA/B29</subfield>
            <subfield code="9">info:eu-repo/grantAgreement/ES/MINECO/SAF2017-83120-C2-1-R</subfield>
        </datafield>
        <datafield tag="540" ind1=" " ind2=" ">
            <subfield code="9">info:eu-repo/semantics/openAccess</subfield>
            <subfield code="a">by</subfield>
            <subfield code="u">http://creativecommons.org/licenses/by/3.0/es/</subfield>
        </datafield>
        <datafield tag="590" ind1=" " ind2=" ">
            <subfield code="a">6.126</subfield>
            <subfield code="b">2019</subfield>
        </datafield>
        <datafield tag="591" ind1=" " ind2=" ">
            <subfield code="a">ONCOLOGY</subfield>
            <subfield code="b">37 / 244 = 0.152</subfield>
            <subfield code="c">2019</subfield>
            <subfield code="d">Q1</subfield>
            <subfield code="e">T1</subfield>
        </datafield>
        <datafield tag="592" ind1=" " ind2=" ">
            <subfield code="a">1.938</subfield>
            <subfield code="b">2019</subfield>
        </datafield>
        <datafield tag="593" ind1=" " ind2=" ">
            <subfield code="a">Oncology</subfield>
            <subfield code="c">2019</subfield>
            <subfield code="d">Q1</subfield>
        </datafield>
        <datafield tag="593" ind1=" " ind2=" ">
            <subfield code="a">Cancer Research</subfield>
            <subfield code="c">2019</subfield>
            <subfield code="d">Q1</subfield>
        </datafield>
        <datafield tag="655" ind1=" " ind2="4">
            <subfield code="a">info:eu-repo/semantics/article</subfield>
            <subfield code="v">info:eu-repo/semantics/publishedVersion</subfield>
        </datafield>
        <datafield tag="700" ind1=" " ind2=" ">
            <subfield code="0">(orcid)0000-0003-0154-0730</subfield>
            <subfield code="a">Pardo, Julián</subfield>
            <subfield code="u">Universidad de Zaragoza</subfield>
        </datafield>
        <datafield tag="700" ind1=" " ind2=" ">
            <subfield code="a">Escors, David</subfield>
        </datafield>
        <datafield tag="700" ind1=" " ind2=" ">
            <subfield code="a">De Vlaeminck, Yannick</subfield>
        </datafield>
        <datafield tag="700" ind1=" " ind2=" ">
            <subfield code="a">Jiang, Heng</subfield>
        </datafield>
        <datafield tag="700" ind1=" " ind2=" ">
            <subfield code="a">Keyaerts, Marleen</subfield>
        </datafield>
        <datafield tag="700" ind1=" " ind2=" ">
            <subfield code="a">De Ridder, Mark</subfield>
        </datafield>
        <datafield tag="700" ind1=" " ind2=" ">
            <subfield code="a">Breckpot, Karine</subfield>
        </datafield>
        <datafield tag="710" ind1="2" ind2=" ">
            <subfield code="1">1008</subfield>
            <subfield code="2">566</subfield>
            <subfield code="a">Universidad de Zaragoza</subfield>
            <subfield code="b">Dpto. Microb.Med.Pr.,Sal.Públ.</subfield>
            <subfield code="c">Área Inmunología</subfield>
        </datafield>
        <datafield tag="773" ind1=" " ind2=" ">
            <subfield code="g">11, 6 (2019), 808  [17 pp.]</subfield>
            <subfield code="p">Cancers</subfield>
            <subfield code="t">Cancers</subfield>
            <subfield code="x">2072-6694</subfield>
        </datafield>
        <datafield tag="856" ind1="4" ind2=" ">
            <subfield code="s">1696035</subfield>
            <subfield code="u">http://zaguan.unizar.es/record/86997/files/texto_completo.pdf</subfield>
            <subfield code="y">Versión publicada</subfield>
        </datafield>
        <datafield tag="856" ind1="4" ind2=" ">
            <subfield code="s">103590</subfield>
            <subfield code="u">http://zaguan.unizar.es/record/86997/files/texto_completo.jpg?subformat=icon</subfield>
            <subfield code="x">icon</subfield>
            <subfield code="y">Versión publicada</subfield>
        </datafield>
        <datafield tag="909" ind1="C" ind2="O">
            <subfield code="o">oai:zaguan.unizar.es:86997</subfield>
            <subfield code="p">articulos</subfield>
            <subfield code="p">driver</subfield>
        </datafield>
        <datafield tag="951" ind1=" " ind2=" ">
            <subfield code="a">2020-07-16-09:35:23</subfield>
        </datafield>
        <datafield tag="980" ind1=" " ind2=" ">
            <subfield code="a">ARTICLE</subfield>
        </datafield>
    </record>

    
</collection>